RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer

NCT02161419 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Carcinoma

Interventions

DRUG: Roniciclib (BAY1000394)
DRUG: Placebo

Sponsor

Bayer